Did some digging about the cccDNA inhibitor that was called the ccc_r08.
Here’s the Roche patent for it.
WO2020052774 FLAVONE DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS DISEASE
Just hope they are doing their best making it the “holy grail” that is found. But the sad part is Pharma will need years to even start phase 1 trials.
Just a reminder that Roche also dropped a Phase 2 anti-hbv candidate RG7907 a few months back.
We can only hope for now.